Guardian Pharmacy Services (NYSE:GRDN) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) issued its quarterly earnings results on Monday. The company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.01, Zacks reports.

Guardian Pharmacy Services Price Performance

Guardian Pharmacy Services stock remained flat at $25.63 during trading hours on Monday. 146,737 shares of the company's stock traded hands, compared to its average volume of 146,700. Guardian Pharmacy Services has a 12 month low of $14.16 and a 12 month high of $27.99. The business's 50-day simple moving average is $22.13 and its 200-day simple moving average is $21.59.

Analysts Set New Price Targets

Separately, Truist Financial boosted their price target on shares of Guardian Pharmacy Services from $24.00 to $25.00 and gave the stock a "buy" rating in a research note on Friday, April 11th.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.